Animals & Us

The series Animals & Us explores the strong connection between the health of animals and people. In GALVmed’s film, we explore how innovation, collaboration, and vaccination of livestock help protect animals, strengthen communities, and advance One Health.

This video was produced for GALVmed by BBC StoryWorks Commercial Productions.

Watch GALVmed's Story

Year in Review: GALVmed 2025

We’re excited to share GALVmed’s 2025 Year in Review, an overview of our accomplishments and the progress made throughout the year in advancing our mission.

The review reflects a year of meaningful impact and our continued commitment to strengthening livelihoods through improved livestock health.

Read it here.

Our Vision

Transformational improvement in the well-being and economic progression of small-scale livestock producers.

Our Mission

We will contribute to the transformation of small-scale livestock producers’ lives by:

  • understanding the constraints to animal health and how to overcome them;
  • engaging the animal health industry; and
  • ensuring awareness, availability and adoption of effective animal health interventions.

• Approximately 8.6 million cumulative annual customers over the period 2014 to 2025, before adjustment for potential repeat customers • Approximately US$157.9 million in poultry deaths averted, from 2014 to 2025 • 3.89 billion doses of livestock vaccines, therapeutics and other animal health products sold to small-scale producers across Africa and South Asia from 2014 to 2025 • 16 products taken to full development since 2010 • 24 products registered to date under the Mutual Recognition Procedure • US$583.2 million in total net economic benefits to SSPs from the sale of vaccines and animal health products. Of this, US$260.1 million represents additional net economic benefit generated through GALVmed’s efforts to expand market availability and catalyse new adoption.

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Commercial development

Our work with our partners supports the small-scale livestock producers of the world.

Enabling environment

An enabling environment that allows for the successful translation of research products to sustainable animal health solutions for small scale livestock producers is essential to achieving GALVmed’s mission.

Blog

Animals & Us: A new series from WOAH featuring GALVmed

The series Animals & Us explores the strong connection between the health of animals and people.

In GALVmed’s film, we explore how innovation, collaboration, and vaccination of livestock help protect animals, strengthen communities, and advance One Health.

Nigeria Takes a Bold Step Toward Transforming Its Animal Health Sector

Government leaders, veterinary professionals, development partners, academics, and private sector stakeholders came together to deliberate on solutions to the challenges facing the livestock health sector.

New Policy Brief advocates collaborative action to advance access to new veterinary trypanocides for Africa

A new joint policy brief by FAO, WOAH and AU-IBAR advocates for a multi-stakeholder and multi-sectoral collaboration to deliver a new generation of trypanocides for the African livestock sector.

Voices from the field

Animals & Us: A new series from WOAH featuring GALVmed

The series Animals & Us explores the strong connection between the health of animals and people.

In GALVmed’s film, we explore how innovation, collaboration, and vaccination of livestock help protect animals, strengthen communities, and advance One Health.

New Policy Brief advocates collaborative action to advance access to new veterinary trypanocides for Africa

A new joint policy brief by FAO, WOAH and AU-IBAR advocates for a multi-stakeholder and multi-sectoral collaboration to deliver a new generation of trypanocides for the African livestock sector.

GALVmed, University of Toronto and Biovet Enter New Agreement to Advance Next-Generation Haemorrhagic Septicaemia Vaccine for Africa and South Asia

The candidate vaccine is a novel target identified on the surface of haemorrhagic septicaemia-associated strains of Pasteurella multocida. It has demonstrated robust protection in cattle against lethal challenge with the two serogroups of Pasteurella responsible for HS.

Why gender-intentional programmes are key to livestock systems development

Applying a gender lens to livestock programmes is not an optional add-on, but a strategic necessity. VITAL 2 is a gender-intentional investment, designed to ensure that gender-related barriers and norms are identified and addressed so that women are not excluded from the benefits of ruminant vaccination as markets and delivery systems expand.

Showcasing Impact: GALVmed Key Achievements

Over the years, GALVmed through its partners, has implemented impactful programmes across Africa and South Asia, leading to significant achievements.

Read more Voices from the field articles…